January 31, 2026

Genetic Testing Can Save Lives. But Too Many People Are Left Out.

Why access to genetic testing matters for prevention and better care

Care & support
Healthcare access
Workplace benefits
Survivorship
Medication optimization
Genomic Testing
Precision Medicine

Genetic testing can provide individuals with valuable information about their health, including whether they carry genetic changes that increase their risk of developing cancer. However, many people still miss out on this type of testing today. Sometimes it’s because they don’t meet strict insurance requirements, sometimes because of cost, and sometimes simply because their doctor doesn’t suggest it.

At Kadance, we believe that everyone deserves access to the best care and the most advanced testing, regardless of their age, race, or background. That’s why we make genetic testing and expert support a core part of our program from day one.

A recent study in JAMA Network Open highlights the importance of this work.

What the Study Looked At

Researchers studied over 2,400 women with breast cancer, ranging in age from 18 to 93, and from many racial and ethnic backgrounds. Everyone was genetically tested for changes in two important genes: BRCA1 and BRCA2. When changed (or “mutated”), these genes can raise the risk of breast and ovarian cancer, and knowing about those changes can impact treatment decisions and help families understand their own risks.

What They Found

The results showed that narrow rules about who “should” get tested are leaving too many people out:

The takeaway: if testing is limited to certain age groups, family histories, or insurance criteria, many people at risk will be overlooked.

How Kadance Helps

At Kadance, we remove those barriers so more people can benefit from advanced genetic insights. Here’s how:

Closing the Gap

The research makes one thing clear: when access to genetic testing is limited, people are left without information that could change, or even save, their lives. Kadance exists to close that gap. By making genetic testing simple, affordable, and accessible from the start, we help ensure that no one is left behind due to their age, race, or insurance status.

Because everyone deserves the best care.

Resources:

Mortimer JE, Lindsey SS, Zukin E, et al. Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer. JAMA Netw Open. 2025;8(9):e2531577. doi:10.1001/jamanetworkopen.2025.31577

Share this BLOG article